PhRMA member companies are committed to ensuring patients can access the medicines they need to stay healthy and live longer, more productive lives. As part of this pledge, today we relaunched the Partnership for Prescription Assistance (PPA) website to provide patients and caregivers with faster, easier access to information on public and private patient assistance programs.
Hypertension, or high blood pressure, is a chronic condition affecting an estimated 70 million people in the United States.
Unfortunately, just 52 percent of these individuals have their high blood pressure under control.
Many people don’t realize taking their medicines as prescribed can help keep this chronic condition in check – and save money – for both individuals and the health care system overall.
This piece first appeared on WashingtonExec on February 25, 2015.
On Saturday, March 28, the Leukemia & Lymphoma Society (LLS) will host its 2015 Leukemia Ball. This annual black-tie event starts at 6:30 p.m. and will be held at the Walter E. Washington Convention Center, in Washington, D.C.
Many patients are not aware of the harmful effects that non-adherence to needed medicines can have on their health, lifestyle and the economy. This week, we explored the ways in which medication adherence and staying up-to-date on important health-related information can help patients.
Understanding how intrinsic intellectual property (IP) is to the United States economy (innovative industries support more than a quarter of all jobs in the U.S.), the Office of the U.S. Trade Representative (USTR) each year releases the Special 301 Report, which details the trade barriers that exist with our trading partners and places certain countries on designated “watch lists.”
According to the Centers for Disease Control and Prevention, one in three American adults has high cholesterol. For those struggling with high cholesterol, getting needed prescriptions and adhering to the prescribed treatment regimen is critical. As Peggy, a Georgia widow with high cholesterol noted, Medicare Part D has relieved the stress of having to decide between purchasing vital medicines or food, and as a result, she can now treat her chronic condition consistently.
I am excited to be in India this week to discuss the scientific landscape of pharmaceutical research and development. Everywhere I go I see so much potential for India to become a leader in the discovery and development of innovative medicines. India has a large cadre of well-trained pharmaceutical scientists and has more U.S. FDA-approved pharmaceutical facilities than any other foreign country. This country is ripe for growth in discovering and developing new medicines, not only for the people of India but others around the world.
For 50 years, the PhRMA Foundation has supported young scientists in their efforts to pursue careers in research and education that will ultimately lead to improved care and treatment options for patients. With our continued commitment to this goal in mind, I’m excited to announce the launch of the Foundation’s new web platform, www.phrmafoundation.org, which offers new resources on our competitive research grants and fellowships in the most challenging areas of drug discovery.
Managing diabetes treatments is a big task. Medicare Part D helps patients access needed medicines, keeps costs low and helps avoid costly hospitalizations and complications. According to Betty, a mother of five from California, she can afford her diabetes prescriptions thanks to Part D and feels more secure as a result.
The internet provides us with a wealth of information right at our fingertips, but it’s important to be mindful of misinformation, especially as it pertains to your health. With myths and facts swirling about important health topics this week, we cut through the clutter to bring you the facts.